Memory-altering drugs: Shifting the paradigm of informed consent

American Journal of Bioethics

Volumn 7, Issue 9, 2007, Pages 40-42

  Tenenbaum, Evelyn M ^a   Reese, Brian ^a  

^a ALBANY LAW SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

BIOETHICS; DRUG EFFECT; HUMAN; INFORMED CONSENT; MEMORY; NOTE; POSTTRAUMATIC STRESS DISORDER; PSYCHOLOGICAL ASPECT;

ADRENERGIC BETA-ANTAGONISTS; BIOETHICAL ISSUES; HUMANS; INFORMED CONSENT; MEMORY; PROPRANOLOL; STRESS DISORDERS, POST-TRAUMATIC;

EID: 34548553161     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160701518649     Document Type: Note

References (6)

1. Gatter, R. 2000. Informed consent and the forgotten duty of physician inquiry. Loyola University Chicago Law Journal 31: 557-597.
2. Henry, M., J. R. Fishman, and S. J. Younger. 2007. Propranolol and the prevention of post-traumatic stress disorder: Is it wrong to erase the "sting" of bad memories? American Journal of Bioethics (AJOB-Neuroscience) 7(9): 12-20.
3. Kisch, W. 1996. From the couch to the bench: How should the legal system respond to recovered memories of childhood sexual abuse? American University Journal of Gender and the Law 5:207-246.
4. Kolber, A. J. 2006. Therapeutic forgetting: The legal and ethical implications of memory dampening. Vanderbilt Law Review 59(5):1561-1626.
5. President's Council on Bioethics 2003. Beyond therapy: Biotechnology and the pursuit of happiness. Washington, DC: Government Printing Office.
6. Posner, E. 2001. Law and the emotions. Georgetown Law Journal 89: 1977-2012.